Literature DB >> 301715

The intraocular pressure response of glaucomatous eyes to topically applied bupranolol. A pilot study.

G K Krieglstein, J Sold-Darseff, W Leydhecker.   

Abstract

Bupranolol 0.5% oily solution applied topically lowered intraocular pressure of glaucomatous eyes significantly. The pressure decrease is related to pretreatment pressure levels. The maximum effect occurred within 4 hours and lasted for more than 24 hours. No objective or subjective irritation could be attributed to the ophthalmic preparation. There was no significant effect on outflow facility, on blood pressure or tear flow. However, bupranolol produces local anesthesia on the eye. The problem of tachyphylaxis is discussed in the treatment of glaucoma with bupranolol eye drops.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301715     DOI: 10.1007/bf00410994

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  8 in total

1.  Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.

Authors:  M J Elliot; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

2.  Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

Authors:  I M Katz; W A Hubbard; A J Getson; A L Gould
Journal:  Invest Ophthalmol       Date:  1976-06

3.  Topical propranolol and ocular tension in the human.

Authors:  J Vale; A C Gibbs; C I Phillips
Journal:  Br J Ophthalmol       Date:  1972-10       Impact factor: 4.638

4.  [Treatment of angina pectoris and arrthymias with a beta receptor blockader].

Authors:  D Willems; P Frisch; H Klepzig
Journal:  Z Kreislaufforsch       Date:  1971-04

5.  [Studies on 1-(6'-chloro-3'-methylphenoxy)-3-tert.-butylaminopropan-2-ol-hydrochloride (KL 255). 1. Tolerance in men under rest conditions].

Authors:  E Waterloh; H F Rittel; E Leide
Journal:  Arzneimittelforschung       Date:  1969-02

6.  Effect of pindolol on intraocular pressure.

Authors:  I Bonomi; P Steindler
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

7.  The effect of some beta-adrenergic blockers on human intraocular pressure.

Authors:  E D el-Sharaf; E A Haroun; Z Ishaac; T M el-Shewy; A H el-Nassef
Journal:  Exp Eye Res       Date:  1974-09       Impact factor: 3.467

8.  Pathology of practolol-induced ocular toxicity.

Authors:  A H Rahi; C M Chapman; A Garner; P Wright
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

  8 in total
  5 in total

1.  The effect of betablockers with and without ISA on tonographic outflow facility.

Authors:  M Diestelhorst; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

2.  The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study.

Authors:  W Leydhecker; G K Krieglstein
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-04-02

3.  Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.

Authors:  K Wettrell; K Wilke; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

4.  Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.

Authors:  F E Ros; C L Dake; N J Nagelkerke; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-06-19

5.  Timolol in operated closed-angle glaucoma.

Authors:  C I Phillips
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.